"The ability to further scale the delivery of goods to the home will advance the rapidly growing hospital-at-home market, driving scale and efficiency for Medically Home's high-acuity care model," said Rami Karjian, CEO of Medically Home. Potential benefits include cost savings due to reduced overhead and more efficient clinician protocols, increased safety due to a reduced risk of hospital-acquired infections and medical errors, plus increased patient satisfaction. The same research demonstrates how stakeholders - including payers, healthcare facilities and physician groups, home-based care providers, technology companies and investors-could see substantial value by providing patients with care in the comfort of their homes 1. The Velocare pilot includes real-time evaluation of the technology, service levels, effectiveness, patient experiences, plus consideration for future growth in new markets.Ī recent study by McKinsey & Company estimates that up to $265 billion worth of care services for Medicare fee-for-service and Medicare Advantage beneficiaries could shift to the home by 2025 without a reduction in quality or access 1. With the right infrastructure in place, patients who were historically admitted to brick-and-mortar hospitals such as those with severe pneumonia, complicated urinary tract infections, cellulitis, blood infections and congestive heart failure exacerbations can now receive high-quality, safe, hospital-level care in the comfort of their homes. Our collaboration is driving scale and efficiency, and ultimately provides positive patient outcomes." "With their mission of putting the patient at the center of care, combined with their differentiated supply chain network, Medically Home leads the way in bringing the hospital home. "We're excited to further expand our at-Home Solutions supply chain and logistics excellence to now reach patients receiving hospital-level care at home," said Rob Schlissberg, president, at-Home Solutions. The pilot will test the use of new technology, new order handling processes, small-format depots and short-haul delivery vehicles to enable safe and consistent hospital-level care in the home. Legacy Cardinal Health capabilities include global logistics and distribution expertise, management of a large network of suppliers and vendors, and access to a wide range of home-based care providers. The cushioning is slightly softer and more progressive than the type we use on our racing saddles, providing more long-distance comfort.Īrgo is a product of the fizik Concepts program, a cross-disciplinary collaboration of leading industry experts and academics carrying out research and analysis on technology, design, physiology, and bike-fitting in search of ways to improve cycling performance.Velocare brings together Cardinal Health capabilities through a combined offering intended for health systems, payers, digital health companies, telehealth providers and other entities moving high-acuity care to the home. The padding is made from fizik's proprietary Type 2 foam formulation, slightly thicker around the ischial sit bones area to support a more upright riding posture. As the endurance riding option, Tempo Argo has been engineered to deliver a riding feel that suits the balanced geometry of today's all-purpose road machines. It also features an ergonomic cutout that was developed using detailed pressure analysis and input from medical experts.Īrgo is our most versatile saddle shape and each version suits different riding styles. Tempo Argo's short length allows the rider to sit further forward without placing undue pressure on sensitive tissues. Where a traditional saddle shape encourages riders to shift their position frequently for better leverage, Argo puts the rider in a more planted position, making for greater stability and better weight distribution. TEMPO ARGO R3 is a versatile endurance road saddle with a short-nose design and generous ischial support that encourages stability.
0 Comments
Leave a Reply. |